Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer

Por Vizza Enrico, Corrado Giacomo, Samaritani Riccardo, Sbiroli Carlo
Publicado em 2007-04-01

Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer

Por Samaritani, Riccardo, Corrado, Giacomo, Vizza, Enrico, Sbiroli, Carlo
Publicado em 2007

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study

Por Ferrandina, Gabriella, Corrado, Giacomo, Mascilini, Floriana, Malaguti, Paola, Samaritani, Riccardo, Distefano, Mariagrazia, Masciullo, Valeria, Di Legge, Alessia, Savarese, Antonella, Scambia, Giovanni
Publicado no BMC Cancer (2014)

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

Por Natoli, Clara, Vici, Patrizia, Sperduti, Isabella, Grassadonia, Antonino, Bisagni, Giancarlo, Tinari, Nicola, Michelotti, Andrea, Zampa, Germano, Gori, Stefania, Moscetti, Luca, De Tursi, Michele, Panebianco, Michele, Mauri, Maria, Ferrarini, Ilaria, Pizzuti, Laura, Ficorella, Corrado, Samaritani, Riccardo, Mentuccia, Lucia, Iacobelli, Stefano, Gamucci, Teresa
Publicado em 2013